Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Assess whether Risk Parity or index funds better suit your retirement plan by examining diversification, cost, and potential risk/return trade-offs.
27,926 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
As AI accelerates, tech’s demand uninterrupted power is forcing investors to rethink NextEra Energy’s renewables-led ...
Apple advances a leadership shift, naming hardware chief John Ternus as the next CEO, effective Sept. 1, 2026. Tim Co...
Rivian’s quality metrics, limited service footprint, and steep pricing are prompting investor caution in 2026. This r...
LegalZoom stock slipped today as markets digested the latest quarter. This article breaks down the drivers behind the...
Anthropic’s Dario Amodei says culture matters more than code in winning the AI race, dedicating up to 40% of his time...
A wave of AI-driven efficiency moves is prompting banks to trim payrolls. The trend rekindles a widely circulated war...
A regional war has unsettled energy markets, prompting a global push toward remote work. Observers say iran reviving ...
Three global e-commerce leaders are trading at bargain prices as reinvestment cycles press on near‑term earnings, pot...
MSFW has fallen sharply since its July 2025 launch, while weekly payouts crater from a peak of $0.97 to a recent $0.1...
Saudi Aramco posts a 25% year-over-year rise in quarterly profit, supported by higher exports via the East-West Pipel...
As Mink (INKT) closes 2025, investors want clarity on growth, margins, and cash generation. This analysis breaks down...